Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents this decade ...Middle East

Pharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug patents to expire in the next few years. Both companies reported quarterly earning Thursday, providing insights into how the drug manufacturers are preparing for likely hits to their revenues. Read more...

Hence then, the article about merck and bristol myers squibb are bracing to lose their most lucrative patents this decade was published today ( Thursday 25/04/2024 - 11:21 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents this decade )

Also on site :

• Rising Medical Solutions Achieves Repeat HITRUST (r2) Certification, Demonstrating Ongoing Excellence in Cybersecurity and Data Protection
• Zark Launches Community Inventory Audit to Eliminate Chaos and Recover Revenue for Multifamily Communities
• GRAHAM MEDIA GROUP EXPANDS STEPHANIE SLAGLE'S ROLE TO VICE PRESIDENT, CHIEF REVENUE OFFICER AND GENERAL MANAGER OF WDIV LOCAL 4